Insiders / Tanguler Tolga / Activity
Activity — Tanguler Tolga
46 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $607.4K | -2K -5.81% | 31,769 0.02% of shares | medium |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $248.4K | -767 -2.16% | 34,777 0.03% of shares | medium |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $128.1K | -392 -1.04% | 37,417 0.03% of shares | medium |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $113.1K | -350 -0.98% | 35,544 0.03% of shares | medium |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $107.8K | -329 -0.88% | 37,088 0.03% of shares | medium |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $93.0K | -289 -0.80% | 35,894 0.03% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $88.4K | -272 -0.78% | 34,505 0.03% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $84.0K | -258 -0.68% | 37,809 0.03% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $80.4K | -220 -0.73% | 30,020 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $72.6K | -199 -0.65% | 30,240 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $69.0K | -215 -0.59% | 36,183 0.03% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $67.7K | -208 -0.60% | 34,297 0.03% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $56.1K | -170 -0.46% | 36,818 0.03% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $55.8K | -155 -0.50% | 30,657 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $44.1K | -123 -0.40% | 30,897 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $35.4K | -98 -0.32% | 30,559 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $34.3K | -96 -0.31% | 31,020 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $33.9K | -92 -0.31% | 29,837 0.02% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $33.8K | -106 -0.29% | 36,500 0.03% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $32.9K | -100 -0.27% | 36,988 0.03% of shares | low |
| Mar 4, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $32.6K | -102 -0.28% | 36,398 0.03% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $31.2K | -94 -0.26% | 36,643 0.03% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $30.5K | -85 -0.28% | 30,812 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $29.2K | -90 -0.24% | 38,067 0.03% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $26.8K | -81 -0.22% | 36,737 0.03% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $26.5K | -73 -0.24% | 30,486 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $18.3K | -50 -0.17% | 29,970 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $17.1K | -47 -0.15% | 30,439 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $15.2K | -47 -0.12% | 38,157 0.03% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $15.1K | -41 -0.14% | 29,929 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $14.9K | -42 -0.13% | 31,157 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $14.8K | -40 -0.13% | 29,797 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $14.6K | -41 -0.13% | 31,116 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $13.8K | -39 -0.12% | 31,199 0.02% of shares | low |
| Mar 2, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $12.3K | -37 -0.10% | 36,606 0.03% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $7.1K | -19 -0.06% | 29,743 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $7.0K | -19 -0.06% | 29,778 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $5.7K | -15 -0.05% | 29,728 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $5.2K | -14 -0.05% | 29,762 0.02% of shares | low |
| Jan 12, 2026 | Sell | ALNY Alnylam Pharmaceuticals Inc Common Stock | $745 | -2 -0.01% | 29,776 0.02% of shares | low |
| Mar 2, 2026 | Grant | ALNY Alnylam Pharmaceuticals Inc Common Stock | $0 | +5K +14.26% | 38,204 0.03% of shares | low |
| Feb 27, 2026 | Exercise | ALNY Alnylam Pharmaceuticals Inc Common Stock | $0 | +2K +5.24% | 33,435 0.02% of shares | low |
| Feb 12, 2026 | Grant | ALNY Alnylam Pharmaceuticals Inc Common Stock | $0 | +4K +13.46% | 33,728 0.03% of shares | low |
| Jan 11, 2026 | Grant | ALNY Alnylam Pharmaceuticals Inc Common Stock | $0 | +4K +13.85% | 31,238 0.02% of shares | low |
| Mar 2, 2026 | Grant | ALNY Alnylam Pharmaceuticals Inc Stock Option (right to buy) | — | +10K | 10,480 <0.01% of shares | low |
| Feb 27, 2026 | Exercise | ALNY Alnylam Pharmaceuticals Inc Restricted Stock Units | — | -2K -100.00% | 0 0.00% of shares | low |